60 related articles for article (PubMed ID: 867486)
1. Cytotoxic cell-mediated response to tumor antigens on somatic cell hybrids.
Trinchieri G; Aden DP; Solter D; Knowles BB
Transplant Proc; 1977 Mar; 9(1):1161-5. PubMed ID: 867486
[No Abstract] [Full Text] [Related]
2. Augmentation of syngeneic tumor-specific immunity by semiallogeneic cell hybrids.
Toffaletti DL; Darrow TL; Scott DW
J Immunol; 1983 Jun; 130(6):2982-6. PubMed ID: 6189910
[TBL] [Abstract][Full Text] [Related]
3. Somatic cell hybrids between mouse peritoneal macrophages and SV40-transformed human cells. III. Identification of surface antigens coded for by human chromosomes 7 and 17.
Cicurel L; Croce CM
J Immunol; 1977 Jun; 118(6):1951-6. PubMed ID: 193988
[TBL] [Abstract][Full Text] [Related]
4. In vitro sensitization and induction of syngeneic tumor--specific cell--mediated cytotoxicity.
Ferguson RM; Moe M; Simmons RL
Surg Forum; 1976; 27(62):117-9. PubMed ID: 1032910
[No Abstract] [Full Text] [Related]
5. Hybrid resistance to BALB/c plasmacytomas: F1 hybrid anti-MPC-11 immunological responses correlated with resistance to tumor challenge.
Marsili MA; Walker MC; Phillips-Quagliata JM
Cancer Res; 1986 Jan; 46(1):190-7. PubMed ID: 3484380
[TBL] [Abstract][Full Text] [Related]
6. The application of an in vitro cytotoxicity test to studies of the effects of drugs on the cellular immune response in mice. I. Primary response.
Fass L; Fefer A
J Immunol; 1972 Oct; 109(4):749-53. PubMed ID: 5074330
[No Abstract] [Full Text] [Related]
7. Tumor immunity to murine plasma cell tumors. V. Genetic control of the in vitro cytotoxic T-cell response to plasma cell tumor-associated antigens of NZB mice.
Burton RC; Warner NL
J Natl Cancer Inst; 1980 Aug; 65(2):431-40. PubMed ID: 6967529
[TBL] [Abstract][Full Text] [Related]
8. Antitumor immunity induced by hybrid tumor cells: comparison between hybrids and the parental tumor.
O'Donnell RW; Horan PK; Minken TJ; Chuang C; Henshaw EC; McCune CS
Cancer Res; 1984 Feb; 44(2):487-92. PubMed ID: 6318971
[TBL] [Abstract][Full Text] [Related]
9. Native anti-tumor responses elicited by immunization with a low dose of unmodified live tumor cells.
Wu S; Wang SQ; Zhang J; Tan XY; Liu JN
Int J Oncol; 2006 Mar; 28(3):731-6. PubMed ID: 16465379
[TBL] [Abstract][Full Text] [Related]
10. Suppressed development of cytotoxic lymphoid cells in tumor-immunized mice.
Martin WJ; Wunderlich JR; Macdonald J
Isr J Med Sci; 1973 Mar; 9(3):324-31. PubMed ID: 4710040
[No Abstract] [Full Text] [Related]
11. Cell-mediated immunity to H-2 antigens. Characteristics of the effector cells as detected in the microcytotoxicity assay.
Trostmann H; Pfizenmaier K; Wagner H; Röllinghoff M
Transplantation; 1976 Jun; 21(6):446-53. PubMed ID: 1084606
[TBL] [Abstract][Full Text] [Related]
12. An analysis of the sensitivity of somatic cell hybrids to natural killer cell- and natural cytotoxic cell-mediated lysis.
Lin Y; Collins JL; Patek PQ; Cohn M
J Immunol; 1983 Sep; 131(3):1154-9. PubMed ID: 6604090
[TBL] [Abstract][Full Text] [Related]
13. Studies on the induction and expression of T cell-mediated immunity. XIV. Antigen-nonspecific oxidation-dependent cellular cytotoxicity (ODCC) mediated by sodium periodate oxidation of cytotoxic T lymphocytes.
Fan J; Bonavida B
J Immunol; 1983 Sep; 131(3):1426-32. PubMed ID: 6193189
[TBL] [Abstract][Full Text] [Related]
14. Studies on the induction and expression of T cell-mediated immunity. 3. Amplification by papain of the generation of cytotoxic lymphocytes to allogeneic cells.
Kedar E; Bonavida B
J Immunol; 1974 Oct; 113(4):1386-9. PubMed ID: 4153487
[No Abstract] [Full Text] [Related]
15. Suppression of secondary cellular immunity to a tumor allograft by cyclophosphamide and 1,3-bis(2-chloroethyl)-1-nitrosourea.
Einstein AB; Fass L; Fefer A
Cancer Res; 1975 Mar; 35(3):492-6. PubMed ID: 1078784
[TBL] [Abstract][Full Text] [Related]
16. Target determinants for F1 hybrid anti-parental H-2d cell-mediated lympholysis: self antigens controlled by the D end.
Nakamura I; Nakano K; Cudkowicz G
J Immunol; 1983 May; 130(5):2429-33. PubMed ID: 6187857
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies to human tumor antigens.
Steplewski Z
Transplant Proc; 1980 Sep; 12(3):384-7. PubMed ID: 7222217
[No Abstract] [Full Text] [Related]
18. Tumor induction by immunologically activated murine leukemia virus: cellular immunity early in the graft-vs-host reaction.
Ruddle NH; Armstrong MY; Richards FF
J Immunol; 1974 Feb; 112(2):706-15. PubMed ID: 4149884
[No Abstract] [Full Text] [Related]
19. Interspecies Lewis lung carcinoma x Chinese hamster ovary hybrids as protective agents against Lewis lung carcinoma tumor growth.
Wolfman J; Baumal R; Marks A
Cancer Res; 1985 Dec; 45(12 Pt 1):6341-6. PubMed ID: 4063985
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
Yasuda T; Kamigaki T; Nakamura T; Imanishi T; Hayashi S; Kawasaki K; Takase S; Ajiki T; Kuroda Y
Oncol Rep; 2006 Dec; 16(6):1317-24. PubMed ID: 17089056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
